ESTRACE® (17 Beta-estradiol) Indicated for the symptomatic relief of menopausal symptoms.
Natesto™ is the first and only nasal testosterone replacement therapy approved by FDA. Natesto™ testosterone nasal gel, is approved for the treatment of male hypogonadism, or "Low T”.
Tefina™, a product under development for female orgasmic disorder, is being clinically tested in an ongoing phase II trial involving 240 women in the U.S., Canada and Australia.
TriVair Device
TriVair™ is an award-winning single-use unit-dose dry powder inhalation drug delivery platform with applications for both nasal and pulmonary dosing
Trimel is a specialty pharmaceutical company involved in the sales, distribution and development of Men's health, Women's health and respiratory medicines.
© 2015 by Trimel Pharmaceuticals Corporation